• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型合成补体抑制剂对脓毒症大鼠肝脏糖酵解中间产物的影响。

Effect of a new synthetic complement inhibitor on hepatic glycolytic intermediates in septic rats.

作者信息

Ebata T, Kuttner R E, Apantaku F O, Schumer W

出版信息

Adv Shock Res. 1983;9:275-82.

PMID:6880973
Abstract

Peritonitis and endotoxemia produce similar derangements in carbohydrate metabolism, indicating a common mechanism of action. Endotoxin activates the complement chain by the alternate pathway with the release of chemical mediators. These mediators may be responsible for the changes occurring in hepatic metabolite pools during endotoxemia. This hypothesis was tested with FUT-175, a complement inhibitor, (2-(6-amidino)naphthyl-4-guanidinobenzoate 2HC1). Peritonitis was induced by cecal incision in fasted male rats. FUT-175 was infused in 5% dextrose at a dose of 0.1 mg/ml/h. Survival time was 12.1 +/- 2.3 h in the FUT-175 group and and 6.6 +/- 1.1 h without FUT-175. Three peritonitis groups received either 5% dextrose alone; FUT-175 2.5 mg/100 g by IP injection, or FUT-175 0.1 mg/ml/h by infusion. Liver was sampled at 5 h by freeze-clamping, and metabolites were assayed by UV spectrophotometry. Peritonitis caused 33% decrease in glucose-6-phosphate (G6P), a 2.5-fold increase in fructose diphosphate (FDP), and 3.5-fold increase in lactate. In FUT-175-injected rats, G6P was decreased by 20%, FDP increased only 50%, and lactate doubled. Phosphoenolpyruvate (PEP) levels were increased 30% above peritonitis values. The drug produced a partial normalization of liver metabolites. The data suggest that the anticomplement action prevented the release of potent mediators which otherwise cause physiological changes leading to the metabolic imbalance of septic shock.

摘要

腹膜炎和内毒素血症在碳水化合物代谢方面产生相似的紊乱,表明存在共同的作用机制。内毒素通过替代途径激活补体链并释放化学介质。这些介质可能是内毒素血症期间肝脏代谢物池发生变化的原因。用补体抑制剂FUT-175(2-(6-脒基)萘基-4-胍基苯甲酸2HCl)对这一假设进行了验证。通过对禁食雄性大鼠进行盲肠切开诱导腹膜炎。将FUT-175以0.1mg/ml/h的剂量注入5%葡萄糖溶液中。FUT-175组的存活时间为12.1±2.3小时,未使用FUT-175组的存活时间为6.6±1.1小时。三个腹膜炎组分别单独接受5%葡萄糖溶液;腹腔注射2.5mg/100g的FUT-175,或通过输注给予0.1mg/ml/h的FUT-175。在5小时时通过冷冻钳夹采集肝脏样本,并用紫外分光光度法测定代谢物。腹膜炎导致6-磷酸葡萄糖(G6P)减少33%,二磷酸果糖(FDP)增加2.5倍,乳酸增加3.5倍。在注射FUT-175的大鼠中,G6P减少20%,FDP仅增加50%,乳酸增加一倍。磷酸烯醇丙酮酸(PEP)水平比腹膜炎时的值升高30%。该药物使肝脏代谢物部分恢复正常。数据表明,抗补体作用阻止了强效介质的释放,否则这些介质会引起生理变化,导致感染性休克的代谢失衡。

相似文献

1
Effect of a new synthetic complement inhibitor on hepatic glycolytic intermediates in septic rats.一种新型合成补体抑制剂对脓毒症大鼠肝脏糖酵解中间产物的影响。
Adv Shock Res. 1983;9:275-82.
2
[Hepatic glycolytic intermediates and glucoregulatory enzymes in septic shock due to peritonitis: experimental study in rats].[腹膜炎所致脓毒症休克时肝脏糖酵解中间产物及葡萄糖调节酶:大鼠实验研究]
Nihon Geka Gakkai Zasshi. 1984 Jan;85(1):1-5.
3
A time study of hepatic glycolytic intermediates in endotoxemic and septic rats and mice.
Adv Shock Res. 1980;4:73-85.
4
The influence of glucocorticoids on hepatic glycolytic intermediates in fed peritonitis rats.
Adv Shock Res. 1983;10:175-82.
5
Glucocorticoid action on rat hepatic glycolytic intermediates during experimental peritonitis.
Adv Shock Res. 1981;5:113-21.
6
[Effects of anti-toxic agents in septic shock].[抗毒剂在感染性休克中的作用]
Nihon Geka Gakkai Zasshi. 1989 Sep;90(9):1378-81.
7
Liver gluconeogenic metabolites in young and old rats during septic shock.脓毒症休克期间年轻和老年大鼠肝脏中的糖异生代谢产物
Am Surg. 1988 Jul;54(7):460-2.
8
[Hepatic carbohydrate metabolism in endotoxic shock--effect of a complement inhibitor].[内毒素休克时肝脏碳水化合物代谢——一种补体抑制剂的作用]
Masui. 1983 Aug;32(8):956-61.
9
Glucocorticoid effect on glycolytic intermediates in septic rat heart.
Adv Shock Res. 1981;5:103-11.
10
Altered carbohydrate metabolism in endotoxin-tolerant rats after lead sensitization.铅致敏后内毒素耐受大鼠碳水化合物代谢的改变
Circ Shock. 1984;13(3):233-40.

引用本文的文献

1
Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational.代谢靶向治疗干预能否成功征服 SARS-CoV-2?一种科学合理性。
Biomed Pharmacother. 2020 Nov;131:110694. doi: 10.1016/j.biopha.2020.110694. Epub 2020 Aug 27.
2
Nafamostat prevents hypothermia and improves survival time after administration of lipopolysaccharide in a mouse surgical model.那屈肝素预防脂多糖给药后小鼠手术模型体温过低并延长生存时间。
J Anesth. 2009;23(4):624-7. doi: 10.1007/s00540-009-0792-x. Epub 2009 Nov 18.